Literature DB >> 19836685

[Leishmaniases in France: an update].

P Marty1, C Pomares-Estran, L Hasseine, P Delaunay, H Haas, E Rosenthal.   

Abstract

Leishmaniases are parasitic diseases due to a flagellate protozoan of the genus Leishmania. They are transmitted from mammal to mammal by the bite of an arthropod vector: a female sandfly. Among the different clinical presentations, the zoonotic visceral leishmaniasis (ZVL) is due to Leishmania infantum. Dogs are the reservoir and can develop a deadly disease. ZVL is described in China, Pakistan, Latin America and in the Mediterranean region, particularly in the South of France. In recent years, many asymptomatic carriers have been described. Despite the fact that cases in immunocompromised adults are the majority, the classic Mediterranean ZVL in young children is still observed. The classic triad of symptoms is: fever, pallor, splenomegaly and hepatomegaly in half of the cases. The biological orientation is a low blood count (anemia, leuconeutropenia, and thrombocytopenia) and an inflammatory syndrome. Serological tests are useful, but the diagnosis is made by the identification of the parasite in a bone marrow sample. Today, the treatment is done by the liposomal amphotericin B (AmBisome) and the total dose must to be 20 mg/kg.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836685     DOI: 10.1016/S0929-693X(09)75310-2

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  5 in total

1.  Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis.

Authors:  Emilio Besada; Rune Johan Njålla; Johannes C Nossent
Journal:  Rheumatol Int       Date:  2012-08-12       Impact factor: 2.631

Review 2.  Nuclear weapons and neglected diseases: the "ten-thousand-to-one gap".

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

3.  Visceral leishmaniasis in 26 HIV-negative adults.

Authors:  Hazar Lahlou; Ahmed B Filali; Meryem Alami; Moncef Amrani; Rhizlane Berrady; Samira Rabhi; Wafaa Bono
Journal:  BMC Res Notes       Date:  2011-10-08

4.  Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.

Authors:  Lindon Johoson Diniz Silveira; Thiago José Matos Rocha; Sandra Aparecida Ribeiro; Célia Maria Silva Pedrosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

5.  Epidemiology of visceral leishmaniasis in Algeria: an update.

Authors:  Amel Adel; Amel Boughoufalah; Claude Saegerman; Redgi De Deken; Zahida Bouchene; Abdelkrim Soukehal; Dirk Berkvens; Marleen Boelaert
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.